The Knowledge and Development Gaps were used to identify the following priorities to address within the next 10 years. Seaweed biorefineries face mutually reinforcing barriers: the gap between pilot scale and commercial scale means that there still isn’t a compelling case for large scale investment; The timing of first order priorities here reflects that: the first three set up the foundation: dissemination of information about existing pilots, clear regulatory pathways, and financing. Subsequent actions are need to de-risk the dominant cost and emissions drivers such as drying while making improvements to extract products in a sustainable way through green extraction. Then industrial-scale cascading biorefineries become investable and can scale.

Seaweed biorefineries face mutually reinforcing barriers: the gap between pilot scale and commercial scale means that there still isn’t a compelling case for large scale investment; The timing of first order priorities here reflects that: the first three set up the foundation: dissemination of information about existing pilots, clear regulatory pathways, and financing. Subsequent actions are need to de-risk the dominant cost and emissions drivers such as drying while making improvements to extract products in a sustainable way through green extraction. Then industrial-scale cascading biorefineries become investable and can scale.

Goal:

By 2027, comparable cost, yield, and lifecycle emissions data are publicly available for at least eight pilot or early-commercial biorefinery operations across at least three seaweed species and three world regions, with an open-access modeling tool that lets investors and funders test different configurations before committing capital.

Key actions

• Document what existing pilots have learned about product yields, processing costs, what failed and why with particular attention to product mix
• Develop a standard template for cost and lifecycle emissions analysis that allows direct comparison across different species, locations, and facility types. Require any publicly funded project to report against it
• Build an open-access modeling tool that lets researchers and investors run scenarios (different product mixes, locations, processing approaches) and see the effect on both unit economics and emissions at the same time. The two cannot be optimized independently
• Use the data to identify which two-to-three product combinations offer the clearest path to both profitability and verified climate impact for each major species and region

Key Actors and Roles

Actor group	Specific roles	Rationale
Research institutions	Collect and document existing pilot results; develop the standard analysis template; build and maintain the open-access modeling tool; identify the most promising product combinations by species and region.	Researchers are the right people to do this because investors and regulators will trust independent analysis more than industry self-reporting. Access to real operational data from multiple companies is also a strong draw for researchers — it produces papers that are hard to generate otherwise.
Biorefinery companies	Share operational data — including failures — and participate in cross-project benchmarking. Flag where the standard template doesn't capture something important about their situation.	Pooled data from multiple companies is more useful to each of them individually than their own data alone. Companies that share pre-competitive information build credibility with investors that a single-company pitch cannot match.
NGOs and foundations	Convene the learning process across companies that won't do it themselves; host the shared data platform; turn findings into something funders and policymakers can act on.	A neutral third party can get competing companies into the same room. Field-building NGOs are motivated by sector-level impact, not firm-level returns, which makes them credible conveners.
Government funders	Fund the data collection, the modeling tool, and the synthesis work; make standardized reporting a condition of any grant.	Public funders get much more value out of their investments if the results are comparable and reusable. A reporting condition costs almost nothing to impose and generates returns across every subsequent project funded in the sector.

Goal: By 2027, comparable cost, yield, and lifecycle emissions data are publicly available for at least eight pilot or early-commercial biorefinery operations across at least three seaweed species and three world regions, with an open-access modeling tool that lets investors and funders test different configurations before committing capital. Key actions

• Document what existing pilots have learned about product yields, processing costs, what failed and why with particular attention to product mix.
• Develop a standard template for cost and lifecycle emissions analysis that allows direct comparison across different species, locations, and facility types. Require any publicly funded project to report against it.
• Build an open-access modeling tool that lets researchers and investors run scenarios (different product mixes, locations, processing approaches) and see the effect on both unit economics and emissions at the same time. The two cannot be optimized independently.
• Use the data to identify which two-to-three product combinations offer the clearest path to both profitability and verified climate impact for each major species and region.

Actor group	Specific roles	Rationale and motivation
Research institutions	Collect and document existing pilot results; develop the standard analysis template; build and maintain the open-access modeling tool; identify the most promising product combinations by species and region.	Researchers are the right people to do this because investors and regulators will trust independent analysis more than industry self-reporting. Access to real operational data from multiple companies is also a strong draw for researchers — it produces papers that are hard to generate otherwise.
Biorefinery companies	Share operational data — including failures — and participate in cross-project benchmarking. Flag where the standard template doesn't capture something important about their situation.	Pooled data from multiple companies is more useful to each of them individually than their own data alone. Companies that share pre-competitive information build credibility with investors that a single-company pitch cannot match.
NGOs and foundations	Convene the learning process across companies that won't do it themselves; host the shared data platform; turn findings into something funders and policymakers can act on.	A neutral third party can get competing companies into the same room. Field-building NGOs are motivated by sector-level impact, not firm-level returns, which makes them credible conveners.
Government funders	Fund the data collection, the modeling tool, and the synthesis work; make standardized reporting a condition of any grant.	Public funders get much more value out of their investments if the results are comparable and reusable. A reporting condition costs almost nothing to impose and generates returns across every subsequent project funded in the sector.

Goal:

By 2028, at least three countries have workable permitting pathways for seaweed cultivation and processing facilities, and internationally accepted safety and quality standards are under active development for at least two major product categories — biostimulants and food-grade ingredients being the most urgent.

Key actions

• Map the current regulatory situation in priority markets (what permits are required, how long they take, what the sticking points are) and use that map to target advocacy and reform efforts.
• Work with regulators in at least three countries to develop simplified cultivation permitting pathways that are not fragmented across different regulatory bodies and are designed for seaweed cultivation. Pilot streamlined review processes for early demonstration projects.
• Use safety and contaminant data to develop evidence-based product standards for biostimulants, food-grade proteins, and hydrocolloids. Bring these into international standards processes (e.g. ISO, FAO/WHO) so they don't have to be relitigated market by market.
• Make sure seaweed-derived materials are covered under existing green economy frameworks such as plastic reduction programs, bioeconomy strategies, sustainable procurement policies.

Key Actors and Roles

Actor	Specific roles	Rationale
National regulators	Define permitting processes, set contaminant limits, and create fast-track review mechanisms for early demonstration projects. Engage developers before formal applications are submitted rather than responding to them.	Regulators who engage early shape outcomes rather than react to them. A clear pathway also reduces the volume of ad hoc applications they have to process — in the long run it reduces their workload, not increases it.
Standards bodies (ISO, national equivalents)	Develop product quality and safety standards starting with the two or three anchor products that companies are bringing to market first — alginate, carrageenan, biostimulants.	Seaweed processing is a new product category without standards. Filling that gap is what standards bodies exist to do, and it enables market access that neither companies nor regulators can create on their own.
Universities and analytical labs	Generate the contaminant baseline data and risk characterization studies that regulatory submissions require. Publish results in formats that national regulators in multiple countries can use.	Regulators in most countries require independent scientific evidence for new product categories. Academic and government labs provide the institutional independence that makes that evidence credible.
Industry associations	Aggregate industry input on what standards are technically feasible; coordinate voluntary transparency on environmental and safety performance; participate actively in regulatory consultations.	Standards that don't reflect operational reality impose unnecessary costs. Industry associations are the mechanism through which companies collectively influence policy without each company having to lobby individually.

Goal:

By 2028, at least three countries have workable permitting pathways for seaweed cultivation and processing facilities, and internationally accepted safety and quality standards are under active development for at least two major product categories — biostimulants and food-grade ingredients being the most urgent.

Key actions

• Map the current regulatory situation in priority markets (what permits are required, how long they take, what the sticking points are) and use that map to target advocacy and reform efforts.
• Work with regulators in at least three countries to develop simplified cultivation permitting pathways that are not fragmented across different regulatory bodies and are designed for seaweed cultivation. Pilot streamlined review processes for early demonstration projects.
• Use Priority 1 safety and contaminant data to develop evidence-based product standards for biostimulants, food-grade proteins, and hydrocolloids. Bring these into international standards processes (e.g. ISO, FAO/WHO) so they don't have to be relitigated market by market.
• Make sure seaweed-derived materials are covered under existing green economy frameworks such as plastic reduction programs, bioeconomy strategies, sustainable procurement policies.

Key Actors and Roles

Actor	Specific roles	Rationale
National regulators	Define permitting processes, set contaminant limits, and create fast-track review mechanisms for early demonstration projects. Engage developers before formal applications are submitted rather than responding to them.	Regulators who engage early shape outcomes rather than react to them. A clear pathway also reduces the volume of ad hoc applications they have to process — in the long run it reduces their workload, not increases it.
Standards bodies (ISO, national equivalents)	Develop product quality and safety standards starting with the two or three anchor products that companies are bringing to market first — alginate, carrageenan, biostimulants.	Seaweed processing is a new product category without standards. Filling that gap is what standards bodies exist to do, and it enables market access that neither companies nor regulators can create on their own.
Universities and analytical labs	Generate the contaminant baseline data and risk characterization studies that regulatory submissions require. Publish results in formats that national regulators in multiple countries can use.	Regulators in most countries require independent scientific evidence for new product categories. Academic and government labs provide the institutional independence that makes that evidence credible.
Industry associations	Aggregate industry input on what standards are technically feasible; coordinate voluntary transparency on environmental and safety performance; participate actively in regulatory consultations.	Standards that don't reflect operational reality impose unnecessary costs. Industry associations are the mechanism through which companies collectively influence policy without each company having to lobby individually.

Goal: By 2028, at least three countries have workable permitting pathways for seaweed cultivation and processing facilities, and internationally accepted safety and quality standards are under active development for at least two major product categories — biostimulants and food-grade ingredients being the most urgent. Key actions:

• Map the current regulatory situation in priority markets (what permits are required, how long they take, what the sticking points are) and use that map to target advocacy and reform efforts.
• Work with regulators in at least three countries to develop simplified cultivation permitting pathways that are not fragmented across different regulatory bodies and are designed for seaweed cultivation. Pilot streamlined review processes for early demonstration projects.
• Use Priority 1 safety and contaminant data to develop evidence-based product standards for biostimulants, food-grade proteins, and hydrocolloids. Bring these into international standards processes (e.g. ISO, FAO/WHO) so they don't have to be relitigated market by market.
• Make sure seaweed-derived materials are covered under existing green economy frameworks such as plastic reduction programs, bioeconomy strategies, sustainable procurement policies.

Key Actors and Roles

Actor group	Specific roles	Rationale and motivation
National regulators	Define permitting processes, set contaminant limits, and create fast-track review mechanisms for early demonstration projects. Engage developers before formal applications are submitted rather than responding to them.	Regulators who engage early shape outcomes rather than react to them. A clear pathway also reduces the volume of ad hoc applications they have to process — in the long run it reduces their workload, not increases it.
Standards bodies (ISO, national equivalents)	Develop product quality and safety standards starting with the two or three anchor products that companies are bringing to market first — alginate, carrageenan, biostimulants.	Seaweed processing is a new product category without standards. Filling that gap is what standards bodies exist to do, and it enables market access that neither companies nor regulators can create on their own.
Universities and analytical labs	Generate the contaminant baseline data and risk characterization studies that regulatory submissions require. Publish results in formats that national regulators in multiple countries can use.	Regulators in most countries require independent scientific evidence for new product categories. Academic and government labs provide the institutional independence that makes that evidence credible.
Industry associations	Aggregate industry input on what standards are technically feasible; coordinate voluntary transparency on environmental and safety performance; participate actively in regulatory consultations.	Standards that don't reflect operational reality impose unnecessary costs. Industry associations are the mechanism through which companies collectively influence policy without each company having to lobby individually.

Goal: By 2028, at least three countries have workable permitting pathways for seaweed cultivation and processing facilities, and internationally accepted safety and quality standards are under active development for at least two major product categories — biostimulants and food-grade ingredients being the most urgent. Key actions:

• Map the current regulatory situation in priority markets (what permits are required, how long they take, what the sticking points are) and use that map to target advocacy and reform efforts.
• Work with regulators in at least three countries to develop simplified cultivation permitting pathways that are not fragmented across different regulatory bodies and are designed for seaweed cultivation. Pilot streamlined review processes for early demonstration projects.
• Use Priority 1 safety and contaminant data to develop evidence-based product standards for biostimulants, food-grade proteins, and hydrocolloids. Bring these into international standards processes (e.g. ISO, FAO/WHO) so they don't have to be relitigated market by market.
• Make sure seaweed-derived materials are covered under existing green economy frameworks such as plastic reduction programs, bioeconomy strategies, sustainable procurement policies.

Key Actors and Roles

Actor group	Specific roles	Rationale and motivation
National regulators	Define permitting processes, set contaminant limits, and create fast-track review mechanisms for early demonstration projects. Engage developers before formal applications are submitted rather than responding to them.	Regulators who engage early shape outcomes rather than react to them. A clear pathway also reduces the volume of ad hoc applications they have to process — in the long run it reduces their workload, not increases it.
Standards bodies (ISO, national equivalents)	Develop product quality and safety standards starting with the two or three anchor products that companies are bringing to market first — alginate, carrageenan, biostimulants.	Seaweed processing is a new product category without standards. Filling that gap is what standards bodies exist to do, and it enables market access that neither companies nor regulators can create on their own.
Universities and analytical labs	Generate the contaminant baseline data and risk characterization studies that regulatory submissions require. Publish results in formats that national regulators in multiple countries can use.	Regulators in most countries require independent scientific evidence for new product categories. Academic and government labs provide the institutional independence that makes that evidence credible.
Industry associations	Aggregate industry input on what standards are technically feasible; coordinate voluntary transparency on environmental and safety performance; participate actively in regulatory consultations.	Standards that don't reflect operational reality impose unnecessary costs. Industry associations are the mechanism through which companies collectively influence policy without each company having to lobby individually.

Goal:

By 2030, at least three publicly or philanthropically funded biorefinery facilities are operating at meaningful commercial scale (at least 20,000 tonnes wet weight per year), each built around two to three products chosen for their combined path to profitability and verified climate impact, with two full seasons of operational data (costs, yields, emissions) published and available to replication investors.

Key actions

• Use evidence from pilots to select the demonstration sites and product combinations — each facility should target one of the configurations that analysis identifies as most likely to demonstrate both profitability and climate impact.
• For each facility, require the operator to commit upfront to a specific product set and a written plan for how additional products will be added as cash flow improves. The cascade pathway needs to be part of the design, not an afterthought.
• Embed lifecycle emissions measurement from day one of operations, so the climate case is built in real time alongside the economic case. Don't commission the LCA after the fact.
• Run for at least two full annual seasons to account for process variabilities.
• Publish all operational data openly as a condition of public funding: unit economics, yields, processing costs, LCA results. Replication investors need this to make decisions without having to fund their own feasibility studies.

Key Actors and Roles

Actor group	Specific roles	Rationale and motivation
Philanthropic and public funders	Fund the demonstration facilities outright, and set the product selection, data publication, and reporting conditions as requirements. Accept that this phase is not commercially financeable and that the public investment is what makes the private investment that follows possible.	This is the role that only public and philanthropic capital can play. Proof-of-concept demonstrations are not fundable by private investors precisely because the track record they will generate doesn't yet exist. Public funders are creating the conditions for private capital.
Biorefinery operators	Select product combinations based on the Priority 1 evidence; operate to data quality standards; publish results including anything that didn't work. Treat the open data requirement as the price of access to public funding, not a burden.	Operators who demonstrate a successful proof of concept position themselves as the preferred recipients for follow on funding. Open publication also builds the sector credibility that benefits every subsequent project, including the operator's own expansions.
Research institutions	Provide independent lifecycle emissions measurement embedded in facility operations from the start; verify financial performance claims; publish results in peer-reviewed form.	Independent verification of both the economics and the climate impact is what gives the results credibility with development finance institutions and commercial investors. Researchers are motivated by the ability to publish high-quality papers in a promising field.
Buyers and off-takers	Agree to purchase agreements — even conditional ones — before facilities are commissioned. Guaranteed demand at known prices is what allows operators and funders to plan. Specify clearly what quality standards the products need to meet.	Buyers who engage early get preferred supplier relationships and input into product specifications. Those who wait risk paying more or finding supply already committed. Early engagement is in their commercial interest, not just the sector's.

Goal:

By 2030, at least three publicly or philanthropically funded biorefinery facilities are operating at meaningful commercial scale (at least 20,000 tonnes wet weight per year), each built around two to three products chosen for their combined path to profitability and verified climate impact, with two full seasons of operational data (costs, yields, emissions) published and available to replication investors.

Key actions

• Use evidence from pilots to select the demonstration sites and product combinations — each facility should target one of the configurations that analysis identifies as most likely to demonstrate both profitability and climate impact.
• For each facility, require the operator to commit upfront to a specific product set and a written plan for how additional products will be added as cash flow improves. The cascade pathway needs to be part of the design, not an afterthought.
• Embed lifecycle emissions measurement from day one of operations, so the climate case is built in real time alongside the economic case. Don't commission the LCA after the fact.
• Run for at least two full annual seasons to account for process variabilities.
• Publish all operational data openly as a condition of public funding: unit economics, yields, processing costs, LCA results. Replication investors need this to make decisions without having to fund their own feasibility studies.

Key Actors and Roles

Actor group	Specific roles	Rationale and motivation
Philanthropic and public funders	Fund the demonstration facilities outright, and set the product selection, data publication, and reporting conditions as requirements. Accept that this phase is not commercially financeable and that the public investment is what makes the private investment that follows possible.	This is the role that only public and philanthropic capital can play. Proof-of-concept demonstrations are not fundable by private investors precisely because the track record they will generate doesn't yet exist. Public funders are creating the conditions for private captial.
Biorefinery operators	Select product combinations based on the Priority 1 evidence; operate to data quality standards; publish results including anything that didn't work. Treat the open data requirement as the price of access to public funding, not a burden.	Operators who demonstrate a successful proof of concept position themselves as the preferred recipients for follow on funding. Open publication also builds the sector credibility that benefits every subsequent project, including the operator's own expansions.
Research institutions	Provide independent lifecycle emissions measurement embedded in facility operations from the start; verify financial performance claims; publish results in peer-reviewed form.	Independent verification of both the economics and the climate impact is what gives the results credibility with development finance institutions and commercial investors. Researchers are motivated by the ability to publish high-quality papers in a promising field.
Buyers and off-takers	Agree to purchase agreements — even conditional ones — before facilities are commissioned. Guaranteed demand at known prices is what allows operators and funders to plan. Specify clearly what quality standards the products need to meet.	Buyers who engage early get preferred supplier relationships and input into product specifications. Those who wait risk paying more or finding supply already committed. Early engagement is in their commercial interest, not just the sector's.

By 2030, at least three publicly or philanthropically funded biorefinery facilities are operating at meaningful commercial scale (at least 20,000 tonnes wet weight per year), each built around two to three products chosen for their combined path to profitability and verified climate impact, with two full seasons of operational data (costs, yields, emissions) published and available to replication investors. Key actions

• Use evidence from pilots to select the demonstration sites and product combinations — each facility should target one of the configurations that analysis identifies as most likely to demonstrate both profitability and climate impact.
• For each facility, require the operator to commit upfront to a specific product set and a written plan for how additional products will be added as cash flow improves. The cascade pathway needs to be part of the design, not an afterthought.
• Embed lifecycle emissions measurement from day one of operations, so the climate case is built in real time alongside the economic case. Don't commission the LCA after the fact.
• Run for at least two full annual seasons to account for process variabilities.
• Publish all operational data openly as a condition of public funding: unit economics, yields, processing costs, LCA results. Replication investors need this to make decisions without having to fund their own feasibility studies.

Actor group	Specific roles	Rationale and motivation
Philanthropic and public funders	Fund the demonstration facilities outright, and set the product selection, data publication, and reporting conditions as requirements. Accept that this phase is not commercially financeable and that the public investment is what makes the private investment that follows possible.	This is the role that only public and philanthropic capital can play. Proof-of-concept demonstrations are not fundable by private investors precisely because the track record they will generate doesn't yet exist. Public funders are creating the conditions for private captial.
Biorefinery operators	Select product combinations based on the Priority 1 evidence; operate to data quality standards; publish results including anything that didn't work. Treat the open data requirement as the price of access to public funding, not a burden.	Operators who demonstrate a successful proof of concept position themselves as the preferred recipients for follow on funding. Open publication also builds the sector credibility that benefits every subsequent project, including the operator's own expansions.
Research institutions	Provide independent lifecycle emissions measurement embedded in facility operations from the start; verify financial performance claims; publish results in peer-reviewed form.	Independent verification of both the economics and the climate impact is what gives the results credibility with development finance institutions and commercial investors. Researchers are motivated by the ability to publish high-quality papers in a promising field.
Buyers and off-takers	Agree to purchase agreements — even conditional ones — before facilities are commissioned. Guaranteed demand at known prices is what allows operators and funders to plan. Specify clearly what quality standards the products need to meet.	Buyers who engage early get preferred supplier relationships and input into product specifications. Those who wait risk paying more or finding supply already committed. Early engagement is in their commercial interest, not just the sector's.

Goal:

By 2031, at least two development finance institutions have seaweed biorefinery programs in place — with defined financing structures, community benefit conditions, and blended co-investment terms — ready to deploy capital as soon as Priority 3 demonstration results are published.

Key actions

• Begin engagement with development finance institutions during commercial pilots. Share demonstration designs, expected timelines, and the types of evidence that will be generated. Work backwards from what they need to make a financing decision to what the demonstrations should produce.
• Design blended finance structures that combine concessional public loans with mission-aligned private co-investment — defining upfront what return profile each layer of capital is targeting and what community benefit conditions attach to the public portion.
• Develop community equity models as part of the financing structure, not as an add-on. Farming cooperatives, community land trusts, or municipal ownership stakes should be built into the deal structure from the start, not negotiated after the facility is profitable.
• Create a publicly accessible investment prospectus for seaweed biorefinery replication that gives development finance institutions and impact investors a clear picture of the risk profile, return expectations, and social impact of each configuration.

Key Actors and Roles

Actor	Specific roles	Rationale
Philanthropic and public funders	Fund the demonstration facilities outright, and set the product selection, data publication, and reporting conditions as requirements. Accept that this phase is not commercially financeable and that the public investment is what makes the private investment that follows possible.	This is the role that only public and philanthropic capital can play. Proof-of-concept demonstrations are not fundable by private investors precisely because the track record they will generate doesn't yet exist. Public funders are creating the conditions for private captial.
Biorefinery operators	Select product combinations based on the Priority 1 evidence; operate to data quality standards; publish results including anything that didn't work. Treat the open data requirement as the price of access to public funding, not a burden.	Operators who demonstrate a successful proof of concept position themselves as the preferred recipients for follow on funding. Open publication also builds the sector credibility that benefits every subsequent project, including the operator's own expansions.
Research institutions	Provide independent lifecycle emissions measurement embedded in facility operations from the start; verify financial performance claims; publish results in peer-reviewed form.	Independent verification of both the economics and the climate impact is what gives the results credibility with development finance institutions and commercial investors. Researchers are motivated by the ability to publish high-quality papers in a promising field.
Buyers and off-takers	Agree to purchase agreements — even conditional ones — before facilities are commissioned. Guaranteed demand at known prices is what allows operators and funders to plan. Specify clearly what quality standards the products need to meet.	Buyers who engage early get preferred supplier relationships and input into product specifications. Those who wait risk paying more or finding supply already committed. Early engagement is in their commercial interest, not just the sector's.

Goal: By 2031, at least two development finance institutions have seaweed biorefinery programs in place — with defined financing structures, community benefit conditions, and blended co-investment terms — ready to deploy capital as soon as Priority 3 demonstration results are published. Key actions:

• Begin engagement with development finance institutions during commercial pilots. Share demonstration designs, expected timelines, and the types of evidence that will be generated. Work backwards from what they need to make a financing decision to what the demonstrations should produce.
• Design blended finance structures that combine concessional public loans with mission-aligned private co-investment — defining upfront what return profile each layer of capital is targeting and what community benefit conditions attach to the public portion.
• Develop community equity models as part of the financing structure, not as an add-on. Farming cooperatives, community land trusts, or municipal ownership stakes should be built into the deal structure from the start, not negotiated after the facility is profitable.
• Create a publicly accessible investment prospectus for seaweed biorefinery replication that gives development finance institutions and impact investors a clear picture of the risk profile, return expectations, and social impact of each configuration.

Key Actors and Roles:

Actor group	Specific roles	Rationale and motivation
Philanthropic and public funders	Fund the demonstration facilities outright, and set the product selection, data publication, and reporting conditions as requirements. Accept that this phase is not commercially financeable and that the public investment is what makes the private investment that follows possible.	This is the role that only public and philanthropic capital can play. Proof-of-concept demonstrations are not fundable by private investors precisely because the track record they will generate doesn't yet exist. Public funders are creating the conditions for private captial.
Biorefinery operators	Select product combinations based on the Priority 1 evidence; operate to data quality standards; publish results including anything that didn't work. Treat the open data requirement as the price of access to public funding, not a burden.	Operators who demonstrate a successful proof of concept position themselves as the preferred recipients for follow on funding. Open publication also builds the sector credibility that benefits every subsequent project, including the operator's own expansions.
Research institutions	Provide independent lifecycle emissions measurement embedded in facility operations from the start; verify financial performance claims; publish results in peer-reviewed form.	Independent verification of both the economics and the climate impact is what gives the results credibility with development finance institutions and commercial investors. Researchers are motivated by the ability to publish high-quality papers in a promising field.
Buyers and off-takers	Agree to purchase agreements — even conditional ones — before facilities are commissioned. Guaranteed demand at known prices is what allows operators and funders to plan. Specify clearly what quality standards the products need to meet.	Buyers who engage early get preferred supplier relationships and input into product specifications. Those who wait risk paying more or finding supply already committed. Early engagement is in their commercial interest, not just the sector's.

Goal: By 2031, at least two development finance institutions have seaweed biorefinery programs in place — with defined financing structures, community benefit conditions, and blended co-investment terms — ready to deploy capital as soon as Priority 3 demonstration results are published. Key actions:

• Begin engagement with development finance institutions during commercial pilots. Share demonstration designs, expected timelines, and the types of evidence that will be generated. Work backwards from what they need to make a financing decision to what the demonstrations should produce.
• Design blended finance structures that combine concessional public loans with mission-aligned private co-investment — defining upfront what return profile each layer of capital is targeting and what community benefit conditions attach to the public portion.
• Develop community equity models as part of the financing structure, not as an add-on. Farming cooperatives, community land trusts, or municipal ownership stakes should be built into the deal structure from the start, not negotiated after the facility is profitable.
• Create a publicly accessible investment prospectus for seaweed biorefinery replication that gives development finance institutions and impact investors a clear picture of the risk profile, return expectations, and social impact of each configuration.

Key Actors and Roles:

Actor group	Specific roles	Rationale and motivation
Philanthropic and public funders	Fund the demonstration facilities outright, and set the product selection, data publication, and reporting conditions as requirements. Accept that this phase is not commercially financeable and that the public investment is what makes the private investment that follows possible.	This is the role that only public and philanthropic capital can play. Proof-of-concept demonstrations are not fundable by private investors precisely because the track record they will generate doesn't yet exist. Public funders are creating the conditions for private captial.
Biorefinery operators	Select product combinations based on the Priority 1 evidence; operate to data quality standards; publish results including anything that didn't work. Treat the open data requirement as the price of access to public funding, not a burden.	Operators who demonstrate a successful proof of concept position themselves as the preferred recipients for follow on funding. Open publication also builds the sector credibility that benefits every subsequent project, including the operator's own expansions.
Research institutions	Provide independent lifecycle emissions measurement embedded in facility operations from the start; verify financial performance claims; publish results in peer-reviewed form.	Independent verification of both the economics and the climate impact is what gives the results credibility with development finance institutions and commercial investors. Researchers are motivated by the ability to publish high-quality papers in a promising field.
Buyers and off-takers	Agree to purchase agreements — even conditional ones — before facilities are commissioned. Guaranteed demand at known prices is what allows operators and funders to plan. Specify clearly what quality standards the products need to meet.	Buyers who engage early get preferred supplier relationships and input into product specifications. Those who wait risk paying more or finding supply already committed. Early engagement is in their commercial interest, not just the sector's.

Goal:

By 2034, at least five commercial-scale facilities are running three or more product streams with publicly reported multi-season performance data; at least three major buyers have made purchase commitments tied to verified lifecycle performance; processing emissions across the sector are at least 40% lower than the 2025 baseline; and an increasing amount of processing value is retained by farming communities in high-production regions.

Key actions

• Commission full commercial-scale facilities running three or more product streams; require multi-season public reporting as a condition of replication financing; treat each facility as a learning platform, not just a production site.
• Invest in processing innovation — near-site micro-biorefineries, enzyme-based extraction, low-temperature drying — targeting a 40% reduction in processing emissions relative to the current industry baseline. Drying and conventional chemical extraction account for 50–70% of total lifecycle emissions in most current systems and are the highest-priority targets.
• Develop a purchase commitment program — advance market commitments or government procurement contracts — for certified low-emission seaweed products, particularly biostimulants, bioplastics, and food ingredients. Guaranteed demand at known prices is what lets farmers and processors plan beyond the next harvest cycle.
• Build a replication playbook from past lessons: financing templates, permit navigation guides, community engagement protocols, product certification pathways. Make it public so that subsequent projects don't have to start from scratch.
• Design workforce training programs for coastal communities, building the local technical capacity that biorefinery operations require.

Key Actors and Roles

Actor	Specific roles	Rationale
Biorefinery operators	Commission and run full multi-product facilities; publish performance data; develop licensing models that allow the replication playbook to spread without requiring operators to own every facility.	Full-cascade demonstration is the commercial proof that attracts the next round of private investment and licenses. The demonstration-to-licensing model generates revenue without proportional capital outlay — a strong incentive for operators who have already built the operational knowledge.
Governments and procurement agencies	Set up purchase commitment programs for low-emission seaweed products; integrate biorefineries into coastal development plans; require community benefit agreements as a standard condition of permits and subsidies.	Government procurement is the most direct lever for creating the demand signal that lets farmers and processors make multi-year investments. Community benefit conditions are the mechanism through which public funding generates equitable returns rather than concentrating value upstream.
Development finance institutions	Deploy capital from Priority 4 financing structures to replicate proven configurations in developing-country coastal regions; structure investments to include community equity stakes; fund workforce development programs.	Coastal seaweed production is concentrated in developing countries whose governments lack the capital and technical capacity to fund replication independently. Development finance bridges that gap while ensuring community and equity conditions are embedded in the deal structure, not bolted on later.
Seaweed farming cooperatives	Take equity stakes in processing facilities; manage primary processing and supply coordination; participate in the design of community benefit frameworks rather than accepting terms set by others.	Cooperative equity is the mechanism that breaks the price-taker dynamic. Processing margin that currently flows to external investors stays in the community. That isn't just fairer — it creates a more stable supply chain because farmers have a financial stake in the facility's success, not just a contract to fulfill.
Processing technology developers	Develop and commercialize near-site processing equipment, enzyme-based extraction systems, and low-energy drying technologies that cut both costs and emissions. Target the configurations identified earlier as most commercially promising.	Near-site processing is an unsolved market opportunity. Companies that develop practical equipment for the 2–3 product configurations proven earlier enter a market with demonstrated demand and no existing competition. The public data published in Priorities 1 and 3 is the market research they would otherwise have to fund themselves.

 

Goal: By 2034, at least five commercial-scale facilities are running three or more product streams with publicly reported multi-season performance data; at least three major buyers have made purchase commitments tied to verified lifecycle performance; processing emissions across the sector are at least 40% lower than the 2025 baseline; and an increasing amount of processing value is retained by farming communities in high-production regions. Key actions

• Commission full commercial-scale facilities running three or more product streams; require multi-season public reporting as a condition of replication financing; treat each facility as a learning platform, not just a production site.
• Invest in processing innovation — near-site micro-biorefineries, enzyme-based extraction, low-temperature drying — targeting a 40% reduction in processing emissions relative to the current industry baseline. Drying and conventional chemical extraction account for 50–70% of total lifecycle emissions in most current systems and are the highest-priority targets.
• Develop a purchase commitment program — advance market commitments or government procurement contracts — for certified low-emission seaweed products, particularly biostimulants, bioplastics, and food ingredients. Guaranteed demand at known prices is what lets farmers and processors plan beyond the next harvest cycle.
• Build a replication playbook from past lessons: financing templates, permit navigation guides, community engagement protocols, product certification pathways. Make it public so that subsequent projects don't have to start from scratch.
• Design workforce training programs for coastal communities, building the local technical capacity that biorefinery operations require.

Key Actors and Roles:

Actor group	Specific roles	Rationale and motivation
Biorefinery operators	Commission and run full multi-product facilities; publish performance data; develop licensing models that allow the replication playbook to spread without requiring operators to own every facility.	Full-cascade demonstration is the commercial proof that attracts the next round of private investment and licenses. The demonstration-to-licensing model generates revenue without proportional capital outlay — a strong incentive for operators who have already built the operational knowledge.
Governments and procurement agencies	Set up purchase commitment programs for low-emission seaweed products; integrate biorefineries into coastal development plans; require community benefit agreements as a standard condition of permits and subsidies.	Government procurement is the most direct lever for creating the demand signal that lets farmers and processors make multi-year investments. Community benefit conditions are the mechanism through which public funding generates equitable returns rather than concentrating value upstream.
Development finance institutions	Deploy capital from Priority 4 financing structures to replicate proven configurations in developing-country coastal regions; structure investments to include community equity stakes; fund workforce development programs.	Coastal seaweed production is concentrated in developing countries whose governments lack the capital and technical capacity to fund replication independently. Development finance bridges that gap while ensuring community and equity conditions are embedded in the deal structure, not bolted on later.
Seaweed farming cooperatives	Take equity stakes in processing facilities; manage primary processing and supply coordination; participate in the design of community benefit frameworks rather than accepting terms set by others.	Cooperative equity is the mechanism that breaks the price-taker dynamic. Processing margin that currently flows to external investors stays in the community. That isn't just fairer — it creates a more stable supply chain because farmers have a financial stake in the facility's success, not just a contract to fulfill.
Processing technology developers	Develop and commercialize near-site processing equipment, enzyme-based extraction systems, and low-energy drying technologies that cut both costs and emissions. Target the configurations identified earlier as most commercially promising.	Near-site processing is an unsolved market opportunity. Companies that develop practical equipment for the 2–3 product configurations proven earlier enter a market with demonstrated demand and no existing competition. The public data published in Priorities 1 and 3 is the market research they would otherwise have to fund themselves.

 

Goal: By 2034, at least five commercial-scale facilities are running three or more product streams with publicly reported multi-season performance data; at least three major buyers have made purchase commitments tied to verified lifecycle performance; processing emissions across the sector are at least 40% lower than the 2025 baseline; and an increasing amount of processing value is retained by farming communities in high-production regions. Key actions

• Commission full commercial-scale facilities running three or more product streams; require multi-season public reporting as a condition of replication financing; treat each facility as a learning platform, not just a production site.
• Invest in processing innovation — near-site micro-biorefineries, enzyme-based extraction, low-temperature drying — targeting a 40% reduction in processing emissions relative to the current industry baseline. Drying and conventional chemical extraction account for 50–70% of total lifecycle emissions in most current systems and are the highest-priority targets.
• Develop a purchase commitment program — advance market commitments or government procurement contracts — for certified low-emission seaweed products, particularly biostimulants, bioplastics, and food ingredients. Guaranteed demand at known prices is what lets farmers and processors plan beyond the next harvest cycle.
• Build a replication playbook from past lessons: financing templates, permit navigation guides, community engagement protocols, product certification pathways. Make it public so that subsequent projects don't have to start from scratch.
• Design workforce training programs for coastal communities, building the local technical capacity that biorefinery operations require.

Key Actors and Roles:

Actor group	Specific roles	Rationale and motivation
Biorefinery operators	Commission and run full multi-product facilities; publish performance data; develop licensing models that allow the replication playbook to spread without requiring operators to own every facility.	Full-cascade demonstration is the commercial proof that attracts the next round of private investment and licenses. The demonstration-to-licensing model generates revenue without proportional capital outlay — a strong incentive for operators who have already built the operational knowledge.
Governments and procurement agencies	Set up purchase commitment programs for low-emission seaweed products; integrate biorefineries into coastal development plans; require community benefit agreements as a standard condition of permits and subsidies.	Government procurement is the most direct lever for creating the demand signal that lets farmers and processors make multi-year investments. Community benefit conditions are the mechanism through which public funding generates equitable returns rather than concentrating value upstream.
Development finance institutions	Deploy capital from Priority 4 financing structures to replicate proven configurations in developing-country coastal regions; structure investments to include community equity stakes; fund workforce development programs.	Coastal seaweed production is concentrated in developing countries whose governments lack the capital and technical capacity to fund replication independently. Development finance bridges that gap while ensuring community and equity conditions are embedded in the deal structure, not bolted on later.
Seaweed farming cooperatives	Take equity stakes in processing facilities; manage primary processing and supply coordination; participate in the design of community benefit frameworks rather than accepting terms set by others.	Cooperative equity is the mechanism that breaks the price-taker dynamic. Processing margin that currently flows to external investors stays in the community. That isn't just fairer — it creates a more stable supply chain because farmers have a financial stake in the facility's success, not just a contract to fulfill.
Processing technology developers	Develop and commercialize near-site processing equipment, enzyme-based extraction systems, and low-energy drying technologies that cut both costs and emissions. Target the configurations identified earlier as most commercially promising.	Near-site processing is an unsolved market opportunity. Companies that develop practical equipment for the 2–3 product configurations proven earlier enter a market with demonstrated demand and no existing competition. The public data published in Priorities 1 and 3 is the market research they would otherwise have to fund themselves.